Cargando…
3-Methyladenine-enhanced susceptibility to sorafenib in hepatocellular carcinoma cells by inhibiting autophagy
As an effective targeted therapy for advanced hepatocellular carcinoma (HCC), sorafenib resistance has been frequently reported in recent years, with the activation of autophagy by cancer cells under drug stress being one of the crucial reasons. Sorafenib treatment could enhance autophagy in HCC cel...
Autores principales: | Zhao, Fangfang, Feng, Guohe, Zhu, Junyao, Su, Zhijun, Guo, Ruyi, Liu, Jiangfu, Zhang, Huatang, Zhai, Yongzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952045/ https://www.ncbi.nlm.nih.gov/pubmed/33395067 http://dx.doi.org/10.1097/CAD.0000000000001032 |
Ejemplares similares
-
eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma
por: Fang, Chao, et al.
Publicado: (2021) -
Autophagy Inhibition via Hydroxychloroquine or 3-Methyladenine Enhances Chemotherapy-Induced Apoptosis in Neuro-Blastoma and Glioblastoma
por: Wear, Darcy, et al.
Publicado: (2023) -
Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases
por: Yan, Yuan, et al.
Publicado: (2015) -
Inhibition of autophagy with 3-methyladenine is protective in a
lethal model of murine endotoxemia and polymicrobial sepsis
por: Li, Qirui, et al.
Publicado: (2018) -
S-Adenosyl-l-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells
por: Liu, Tsang-Pai, et al.
Publicado: (2015)